Elsevier Health has announced a strategic partnership with OpenEvidence, a company specializing in artificial intelligence for medicine, to develop ClinicalKey AI, a next-generation clinical decision support tool that combines the most recent and reputable evidence-based medical content with generative artificial intelligence (AI) to help physicians at the point of care.
The amount of complex data and information that doctors regularly review and process can be daunting, even for highly experienced clinicians. By combining Elsevier’s trusted medical information with advanced AI technology, ClinicalKey AI can help physicians access accurate evidence-based information at the point of care, added the publisher.
Jan Herzhoff, PhD, president, Elsevier Health said: "We believe ClinicalKey AI can be a game-changer for physicians. By pairing our world-class medical content and technological expertise with the strong AI capability that OpenEvidence is known for, we can take a giant leap forward in the way physicians find and use information at the point of care. ClinicalKey AI is tailor-made for time-pressed physicians who need access to precise answers to a wide range of clinical questions that are backed by the latest and most trusted scientific research, as well as responsible AI principles."
Scott D. Solomon, MD, professor of medicine at Harvard Medical School and Brigham and Women’s Hospital, and Editor, Braunwald’s Heart Disease added: "ClinicalKey AI is exactly the type of solution that physicians need. The product offers a natural language interface with curated content and constantly refreshed evidence-based research that is essential for medical education and point-of-care decision making. It’s clear Elsevier Health has listened to physicians and understands the challenges they face with data overload and concerns about the ethical use of AI in clinical practice. ClinicalKey AI is a significant advancement based on the solutions that are available today and I look forward to having the product broadly available next year."
Daniel Nadler, PhD, founder of OpenEvidence said: "We are energized to partner with a global leader like Elsevier Health, which has a deep heritage in medical information and analytics and shares our mission of improving healthcare outcomes globally. By working together, we will have a greater impact in addressing some of the most significant challenges physicians face every day. OpenEvidence's AI will power Elsevier's trusted medical content in the places and at the moments when physicians need it most.”
The company says its flagship product, ClinicalKey, is a clinical decision support and reference tool used by thousands of hospital systems and medical schools across the globe that supports point of care and deep reference needs. The new capability, ClinicalKey AI, offers a highly advanced conversational search interface to help physicians find accurate, succinct clinical information based on one of the world’s largest and most trusted body of medical information available to date.
Elsevier says some of the key benefits of ClinicalKey AI include:
- Conversational search to accelerate access to evidence-based clinical information: Physicians can get treatment, condition and drug-related questions answered swiftly using a natural language interface. The underlying body of medical content will be continuously updated with the latest clinical insights and underscoring the quality of the sources. The enhanced solution is designed to help support physicians’ clinical workflow and productivity.
- Addressing complex medical questions with evidence-based information: Physicians can address challenging patient cases by getting access to a combination of the latest research, reference textbooks, clinical overviews, drug information and much more that clinicians trust. Physicians will also see citation links and underlying documents that were used to answer their questions to give them the ability to review the primary source documents. Finally, ClinicalKey AI will support follow-up questions and will recommend related ones for the physicians to consider. All content is licensed so users and institutions can feel confident in the information they are using.
- Responsible AI Principles: ClinicalKey AI adheres to industry data privacy and security standards as well as Elsevier's Responsible AI principles.
For more than two decades, Elsevier says it has been using AI and machine learning technologies in combination with its peer-reviewed content and extensive data sets to create products that help the research, life sciences and healthcare communities be more effective every day. By incorporating generative AI in its offerings, Elsevier aims to make it easier and more intuitive for customers to find the information they can trust to accelerate scientific discovery, empower collaboration and transform patient care.
The publisher says ClinicalKey AI will be available for early access starting in November 2023 with a full-scale US launch starting in early 2024.
To learn more and register interest, click here.Keep up-to-date with publishing news: sign up here for InPubWeekly, our free weekly e-newsletter.